Pharmacotherapy: A Pathophysiologic Approach

Have a Promotion Code?

Please enter it here:

Great deals and more!

Sign up for special offers, exclusive discounts, and new product announcements from McGraw-Hill Professional.

SIGN UP TODAY

Related Subscription Sites



Date

July 6, 2008

Format

Mixed media product, 2784 pages

ISBN

0071643257 / 9780071643252

$

Your Price

206.00



Overview


Main description

The benchmark evidence-based pharmacotherapy text-now in full color!

Additional chapters are available online

When it comes to helping you develop a mastery of evidence-based medicine for optimal patient outcomes, no book can match Pharmacotherapy: A Pathophysiologic Approach. Like the discipline it covers, the scope of this trusted resource goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs.

The book also delves into psychosocial issues that affect compliance … topics related to a patient's ability to understand and manage often-complex therapy… and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes. Pharmacotherapy delivers everything you need to provide safe, efficacious drug therapy across the full range of therapeutic categories.

FEATURES

  • NEW! Expanded evidence-based recommendations
  • NEW! Extended coverage of the timely issue of palliative care and pain medicine
  • NEW! Important chapters on Pulmonary Hypertension, Disorders of Calcium and Phosphorus Homeostasis, and Multiple Myeloma,
  • Outstanding pedagogy, including:
  • “Key Concepts” highlighted in each chapter
  • “Clinical Presentation” boxes summarize the most common disease signs and symptoms covered in each chapter
  • “Clinical Controversies” boxes-presented in the Treatment sections of the disease-oriented chapters-examine the complicated issues faced by students and clinicians in providing drug therapy
  • Clear therapeutic recommendations in each disease-specific chapter
  • “Evaluation of Therapeutic Outcomes” boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing, or medical care plan


Table of contents

PHARMACOTHERAPY 7/E - Table of Contents

Section 1: Foundation IssuesSection Editor: L. Michael Posey

1.Pharmacoeconomics: Principles, Methods, and Applications (Web-only) Lisa A. Sanchez

2.Health Outcomes and Quality of Life (Web-only) Stephen Joel Coons

3.Evidence-Based Medicine (Web-only) Elaine Chiquette and L. Michael Posey

4.Documentation of Pharmacy Services (Web-only) George E. MacKinnon, III and Neil J. MacKinnon

5.Clinical Pharmacokinetics and Pharmacodynamics Larry A. Bauer

6.Pharmacogenetics Larisa H. Cavallari and Y. W. Francis Lam

7.Pediatrics Milap C. Nahata and Carol Taketomo

8.Geriatrics Catherine I. Starner, Shelly L. Gray, David R. P. Guay, Emily R. Hajjar, Steven M. Handler, and Joseph T. Hanlon

9.Pharmacoepidemiology Andy Stergachis, Thomas K. Hazlet, and Denise Boudreau

10.Clinical Toxicology Peter A. Chyka

11.Emergency Preparedness: Identification and Management of Biological Exposures (Web-only) Colleen M. Terriff, Jason E. Brouillard, Lisa T. Costanigro, and Jessica S. Gruber

12.Emergency Preparedness: Identification and Management of Chemical and Radiological Exposures (Web-only) Greene Shepherd and Richard B. Schwartz

Section 2: Cardiovascular DisordersSection Editor: Robert L. Talbert

13.Cardiovascular Testing Robert Chilton and Robert L. Talbert

14.Cardiopulmonary Resuscitation Jeffrey F. Barletta and Jeffrey L. Wilt

15.Hypertension Joseph J. Saseen and Eric J. MacLaughlin

16.Heart Failure Robert B. Parker, Jo E. Rodgers, and Larisa H. Cavallari

17.Ischemic Heart Disease Robert L. Talbert

18.Acute Coronary Syndromes Sarah A. Spinler and Simon de Denus

19.The Arrhythmias Cynthia A. Sanoski, Marieke Dekker Schoen, and Jerry L. Bauman

20.Diastolic Heart Failure and the Cardiomyopathies

21.Venous Thromboembolism Stuart T. Haines, Daniel M. Witt, and Edith A. Nutescu

22.Stroke Susan C. Fagan, David C. Hess

23.Hyperlipidemia Robert L. Talbert

24.Peripheral Arterial Disease Barbara J. Hoeben and Robert L. Talbert

25.Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock Robert MacLaren, Maria I. Rudis, and Joseph F. Dasta

26.Hypovolemic Shock Brian L. Erstad

Section 3: Respiratory DisordersSection Editor: Robert L. Talbert

27.Introduction to Pulmonary Function Testing Jay I. Peters and Stephanie M. Levine

28.Asthma H. William Kelly and Christine A. Sorkness

29.Chronic Obstructive Pulmonary Disease Dennis M. Williams and Sharya V. Bourdet

30.Pulmonary Hypertension Robert Talbert, Rebecca Boudreaux, Rebecca Owens

31.Drug-Induced Pulmonary Diseases Hengameh H. Raissy, Michelle Harkins, and Patricia L. Marshik

32.Cystic Fibrosis Gary Milavetz

Section 4: Gastrointestinal DisordersSection Editor: Joseph T. DiPiro

33.Evaluation of the Gastrointestinal Tract Keith M. Olsen, Marie A. Chisholm, and Mark W. Jackson

34.Gastroesophageal Reflux Disease Dianne B. Williams and Robert R. Schade

35.Peptic Ulcer Disease Rosemary R. Berardi and Lynda S. Welage

36.Inflammatory Bowel Disease Brian A. Hemstreet and Joseph T. DiPiro

37.Nausea and Vomiting Cecily V. DiPiro

38.Diarrhea, Constipation, and Irritable Bowel Syndrome William J. Spruill and William E. Wade

39.Portal Hypertension and Cirrhosis Julie Sease Altman, Edward G. Timm, and James J. Stragand

40.Drug-Induced Liver Disease William R. Kirchain and Rondall E. Allen

41.Pancreatitis Rosemary R. Berardi and Patricia A. Montgomery

42.Viral Hepatitis Paulina Deming, Renee-Claude Mercier, and Manjunath P. Pai

43.Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity Y. W. Francis Lam

Section 5: Renal DisordersSection Editor: Gary R. Matzke

44Quantification of Renal Function Thomas C. Dowling

45Acute Renal Failure William Dager and Anne Spencer

46Chronic Kidney Disease: Progression-Modifying Therapies Melanie S. Joy, Abhijit Kshirsagar, and Nora Franceschini

47Chronic Kidney Disease: Management of Complications Joanna Q. Hudson

48Hemodialysis and Peritoneal Dialysis (Web-only) Edward F. Foote and Harold J. Manley

49Drug-Induced Kidney Disease Thomas D. Nolin and Jonathan Himmelfarb

50Glomerulonephritis Alan H. Lau

51Drug Therapy Individualization for Patients with Renal Insufficiency Gary R. Matzke and Reginald F. Frye

52Disorders of Sodium and Water Homeostasis James D. Coyle, Melanie S. Joy, and Gerald A. Hladik

53Disorders of Calcium and Phosphorus Homeostasis Amy Barton Pai and Mark Rohrschieb

54Disorders of Potassium and Magnesium Homeostasis Donald F. Brophy and Todd W. B. Gehr

55Acid-Base Disorders Gary R. Matzke, John W. Devlin, and Paul M. Palevsky

Section 6: Neurologic DisordersSection Editor: Barbara G. Wells

56Evaluation of Neurologic Illness Susan C. Fagan and Fenwick T. Nichols

57Multiple Sclerosis Jacquelyn L. Bainbridge and John R. Corboy

58Epilepsy Susan J. Rogers and Jose E. Cavazos

59Status Epilepticus Stephanie J. Phelps, Collin A. Hovinga, and James W. Wheless

60Acute Management of the Brain Injury Patient Bradley A. Boucher and Shelly D. Timmons

61Parkinson's Disease Jack J. Chen, Merlin V. Nelson, and David M. Swope

62Pain Management and Palliative Care Terry J. Baumann and Jennifer Strickland

63Headache Disorders Deborah S. Minor and Marion R. Wofford

Section 7: Psychiatric DisordersSection Editor: Barbara G. Wells

64Evaluation of Psychiatric Illness Patricia A. Marken, Mark E. Schneiderhan, and Stuart Munro

65Childhood Disorders Julie Ann Dopheide, Jane Tran Tesoro, and Michael Malkin

66Eating Disorders Steven C. Stoner

67Alzheimer's Disease Patricia W. Slattum, Russell H. Swerdlow, and Angela Massey Hill

68Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens Paul L. Doering and Lisa A. Boothby

69Substance-Related Disorders: Alcohol, Nicotine, and Caffeine Paul L. Doering, W. Klugh Kennedy, and Lisa A. Boothby

70Schizophrenia M. Lynn Crismon, Tami R. Argo, and Peter F. Buckley

71Depressive Disorders Christian J. Teter, Judith C. Kando, Barbara G. Wells, and Peggy E. Hayes

72Bipolar Disorder Shannon J. Drayton and Benjamin Weinstein

73Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders Cynthia K. Kirkwood, Sarah T. Melton

74Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder Cynthia K. Kirkwood, Eugene H. Makela, and Barbara G. Wells

75Sleep Disorders John M. Dopp and Bradley G. Phillips


Author comments

Joseph T. DiPiro, PharmD, FCCP, Executive Dean, South Carolina School of Pharmacy, Charleston and Columbia, SC

Robert L. Talbert, PharmD, FCCP, BCPS Professor, University of Texas, Austin and University of Texas Health Science Center at San Antonio.

Gary C. Yee, PharmD, FCCP, Professor and Chair of Pharmacy Practice, University of Nebraska Medicial Center, Omaha

Gary R. Matzke, PharmD, FCP, FCCP Associate Dean for Clinical Research and Public Policy, Professor of Pharmacy and Medicine, Virginia Commonwealth University, Richmond, VA

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP, Dean, University of Mississippi, Oxford, MS

L. Michael Posey, BS Pharm, President, PENS Pharmacy Editorial and News Service, Athens, GA


Back cover copy

Job: Dipiro et al.: Pharmacotherapy: A Pathophysiologic Approach, 7e back cover copy; 9780071478991; 007147899X

[title]

Pharmacotherapy:

A Pathophysiologic Approach

Seventh Edition

[authors]

Joseph T. DiPiro

Robert L. Talbert

Gary C. Yee

Gary R. Matzke

Barbara G. Wells

L. Michael Posey

[Burst:]

Additional Chapters Available Online!

[headline]

The benchmark evidence-based pharmacotherapy text-now in full color!

When it comes to helping you develop a mastery of evidence-based medicine for optimal patient outcomes, no book can match Pharmacotherapy: A Pathophysiologic Approach. Like the discipline it covers, the scope of this trusted resource goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs.

The book also delves into psychosocial issues that affect compliance … topics related to a patient's ability to understand and manage often-complex therapy… and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes. Pharmacotherapy delivers everything you need to provide safe, efficacious drug therapy across the full range of therapeutic categories.

FEATURES

  • NEW! Expanded evidence-based recommendations
  • NEW! Extended coverage of the timely issue of palliative care and pain medicine
  • NEW! Important chapters on Pulmonary Hypertension, Disorders of Calcium and Phosphorus Homeostasis, and Multiple Myeloma,
  • Outstanding pedagogy, including:
  • “Key Concepts” highlighted in each chapter
  • “Clinical Presentation” boxes summarize the most common disease signs and symptoms covered in each chapter
  • “Clinical Controversies” boxes-presented in the Treatment sections of the disease-oriented chapters-examine the complicated issues faced by students and clinicians in providing drug therapy
  • Clear therapeutic recommendations in each disease-specific chapter
  • “Evaluation of Therapeutic Outcomes” boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing, or medical care plan

[McGraw-Hill Medical logo]





Copyright 2014 McGraw-Hill Global Education Holdings, LLC

WELCOME!

Before you can enjoy free downloads from McGraw-Hill Professional, we ask that you please provide your email address and country.



Yes, I want to receive other special offer.